Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Investigation of risk genetic variants for multiple primary cancer of esophageal cancer

ABSTRACT: An investigation of single nucleotide polymorphsims (SNPs) to predict multiple primary cancer of patients with esophagal cancer

INSTRUMENT(S): -

ORGANISM(S): Homo Sapiens

SUBMITTER: NTUH

PROVIDER: PRJEB41367 | EVA | 2020-11-18

REPOSITORIES: EVA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Genotyping-EC.vcf.gz	Vcf
	Genotyping-EC.vcf.gz.tbi	Vcf

Items per page:

1 - 2 of 2

Similar Datasets

The activity and safety of sintilimab on high-risk ground glass opacity lesions in multiple primary lung cancer patients

Project description:Lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer death worldwide, of which approximately 85% are non-small cell lung cancer (NSCLC). The overall survival (OS) of patients with advanced NSCLC was significantly prolonged with immune checkpoint inhibitors (ICIs) targeting the programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) axis. For early-stage lung cancer, the 5-year survival rate for patients ranges from 80% in stage IA to 41% in stage IIIA, and many cases relapse after surgical resection. Currently, multiple clinical trials have manifested the encouraging efficacy of neoadjuvant immunotherapy in stage I-IIIA resectable NSCLC. However, the effect of immunotherapy in ultra early-stage NSCLC patients with micro-invasive or even pre-invasive lesions remains unclear. In this study, we aimed to evaluate the activity and safety of sintilimab on high-risk ground glass opacity lesions in multiple primary lung cancer patients.

2024-05-01 | GSE260770 | GEO

Genetic of multiple primary cancers

Project description:Within the frame of inherited cancer predisposition, single gene carriers of pathogenic variants (PVs) have been extensively represented in the literature, whereas the oligogenic coinheritance of heterozygous PVs in cancer-related genes is a poorly studied event. Currently, due to the increment of cancer survivors, the probability of presenting multiple primary cancers (MPC) is higher. This study included MPC patients ≤45 years without known PVs in common cancer predisposition genes. We used whole exome sequencing (WES) of germline and tumoral DNA, chromosomal microarray analysis (CMA) on germline DNA (patient 1-7, and patient 9-10), and karyotype of patient 8to detect variants associated with the disease. The ten patients included in the study presented a mean of 3 cancers per patient. CMA showed two microduplications and one microdeletion, while WES of the germline DNA identified 1-3 single nucleotide variants of potential interest to the disease in each patient and two additional copy number variants. Most of the identified variants were classified as variants of uncertain significance. The mapping of the germline variants into their pathways showed a possible additive effect of these as the cause of the cancer. Twelve somatic samples from 5 patients were available for sequencing. All the germline variants were also present in the somatic samples, while no second hits were identified in the same genes. The sequencing of patients with early cancers, family history and multiple tumors is already a standard of care. However, the growing evidence suggests that patient´s assessment should not stop at the identification of one PV in a cancer predisposition gene.

2024-08-29 | GSE271498 | GEO

Genetic alterations associated with multiple primary malignancies

Project description:Affymetrix OncoScan arrays were used to identify potential driver DNA copy number alterations and somatic mutations that promote the development of multiple primary malignancies in 26 breast cancer patients.

2021-07-14 | GSE165240 | GEO

Genetic of multiple primary cancers

Project description:Genetic of multiple primary cancers

| PRJNA1131824 | ENA

The activity and safety of sintilimab on high-risk ground glass opacity lesions in multiple primary lung cancer patients

Project description:The activity and safety of sintilimab on high-risk ground glass opacity lesions in multiple primary lung cancer patients

| PRJNA1083453 | ENA

Large genomic alteration of 7q in two patients with multiple primary cancers, including triple negative breast cancer, and family history of malignant neoplasms

Project description:A great percentage of patients with multiple primary cancers (MPCs) and family history of cancer are suspected to have a hereditary cancer predisposition syndrome. However, only a small proportion of these cases are explained by mutations in high-penetrance genes, suggesting the involvement of undiscovered genes in cancer predisposition. In this study, we report the molecular and clinical characterization of two unrelated patients with MPCs, a positive family history of cancer, no germline pathogenic mutations in BRCA1, BRCA2 and TP53 genes and large genomic rearrangements mapped on chromosome 7q. Genomic rearrangements were assessed with Affymetrix CytoScan HD Array platform in two unrelated patients (Patient 1 and Patient 2) with multiple primary cancers. Additionally, the mother of Patient 2 and four children (the son of Patient 1 and three children of Patient 2) were also evaluated.

2016-02-15 | E-GEOD-77138 | biostudies-arrayexpress

Airway microbiota in patients with synchronous multiple primary lung cancer: the bacterial topography of the respiratory tract

Project description:Airway microbiota in patients with synchronous multiple primary lung cancer: the bacterial topography of the respiratory tract

| PRJNA823005 | ENA

Spatial transcriptomics based characterization of spatial architecture in human multiple primary lung cancer

Project description:Spatial transcriptomics based characterization of spatial architecture in human multiple primary lung cancer

| PRJNA827183 | ENA

H3K27ac ChIP-seq for primary multiple myeloma patients’ samples (MM1-MM10)

Project description:H3K27ac ChIP-seq for primary multiple myeloma patients’ samples (MM1-MM10)

| PRJNA608681 | ENA

Genetic alterations associated with multiple primary malignancies

Project description:Genetic alterations associated with multiple primary malignancies

| PRJNA693811 | ENA